Zoetis Inc (NYSE:ZTS)

During the Trading Day
47.31 +1.22 / +2.65%
As of 4:02pm ET
Day’s Change
During After-Hours   Switch to standard view »
47.26 -0.0474 / -0.10%
 
Volume: 90.4K
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$23.1B

Company Description

Zoetis, Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The company manages its operations in four geographic regional segments: the United States, Europe/Africa/Middle East, Canada/Latin America and Asia/Pacific. Within each of these regions, it offers a diversified product portfolio, including vaccines, parasiticides, anti-infectives, medicated feed additives and other pharmaceuticals, for both livestock and companion animal customers. The company's origin dates back to Jan 1, 1952, when it was established as a division of Pfizer, Inc. Zoetis was founded in July 2012 and is headquartered in New York, NY.

Contact Information

Zoetis, Inc.
100 Campus Drive
Florham Park New Jersey 07932
P:(973) 822-7000
Investor Relations:

Employees

Shareholders

Other institutional53.66%
Mutual fund holders40.55%
Individual stakeholders17.20%

Top Executives

Juan Ramón AlaixPresident, Chief Executive Officer & Director
Paul S. HerendeenChief Financial Officer & Executive Vice President
Catherine Ann KnuppExecutive VP, President-Research & Development
Alejandro BernalExecutive Vice President & President-EMEA Region
Clinton A. LewisExecutive Vice President & President-US Operations

To view my watchlist

Not a member yet?

Sign up now for a free account